Company Update (NYSE:JNJ): Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations

[PR Newswire] – NEW BRUNSWICK, N.J., June 22, 2016 /PRNewswire/ — Johnson & Johnson (JNJ) today announced that Louise Mehrotra, Vice President of Investor Relations for Johnson & Johnson, will retire in January 2017, after a transition period with her successor. Louise first joined the Johnson & Johnson Family of Companies in 1980, and has led Investor Relations for more than 10 years. “Louise has been a constant advocate for transparency and credibility in our financial communications, a trusted advisor to company management, and her commitment to excellence has led to the development of a best-in-class IR team,” said Dominic J. Caruso, Executive Vice President, Chief Financial Officer of Johnson & Johnson. Read more on this. Johnson & Johnson (JNJ) , valued at $321.65B, opened this morning at $116.54. Shares have traded today between $116.31 and $116.99 per share with a trailing 52-week range being $81.79 to $117.74. JNJ shares are currently priced at 17.58x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 0.52x earnings multiple for the same period. The company pays shareholders $3.20 per share annually in dividends, yielding 2.77%. Consensus earnings for the current quarter by the 19 sell-side analysts covering the stock is an estimate of $1.69 per share, which would be $0.02 worse than the year-ago quarter and a $0.03 sequential increase. Furthermore, our analysis shows the full-year EPS estimate to be $6.61, which would be a $0.41 improvement when compared to the last year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $17.98 Billion. If reported, that would be a 1.07% increase over the year-ago quarter. Recently, Standpoint Research Initiated JNJ at Sell (May 20, 2016). Previously, Goldman upgraded JNJ from Sell to Neutral. The average price target for JNJ shares by the analysts covering it is $117.89, which is 1.16% above where the stock opened. See more in (NYSE:JNJ) Similar Articles: Company Update: Johnson & Johnson (NYSE:JNJ) – Jim Cramer’s Top Takeaways: Oracle, Johnson & Johnson Stock Update: Johnson & Johnson (NYSE:JNJ) – Retired Johnson & Johnson CEO Ralph Larsen, 77, dies in Fla. Market Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Joins First Industry-wide Call for New Collective Action to Address Antimicrobial Resistance